Yes, What Happens If It's First Down Under?
What might be the implications up here if per chance (or evidence) Australia simply and quickly approves Anavex 2-73 for Aussies with Alzheimer's?
Or, in any other country, too?
Appropriately, we are fixed on FDA approval for sale and use in the US. But the problems Anavex drugs successfully treat are global.
How might American media react, at first to an Australian approval? Probably, "Australians approve risky, unproven Alzheimer's drug."
Then, a few months later, when Alzheimer's people all over Australia report living normal lives. "FDA pressed to speed American approval of new Alzheimer's drug."
Maybe just in Mexico, where drugs can be purchased over the counter, without prescriptions?